1. 17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC. (September 2015) Authors: Rini, B.; Stenzl, A.; Zdrojowy, R.; Kogan, M.; Shkolnik, M.; Oudard, S.; Weikert, S.; Bracarda, S.; Crabb, S.; Bedke, J.; Ludwig, J.; Maurer, D.; Mendrzyk, R.; Mahr, A.; Fritsche, J.; Weinschenk, T.; Singh, H.; Kirner, A.; Reinhardt, C.; Eisen, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: results from the phase 3 METEOR study. (February 2017) Authors: Bracarda, S.; Choueiri, T.K.; Powles, T.; Motzer, R.J.; Olencki, T.; Frontera, O.A.; Oudard, S.; Rolland, F.; Tomczak, P.; Castellano, D.; Appleman, L.; Drabkin, H.; Vaena, D.; Milwee, S.; Youkstetter, J.; Escudier, B. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0146: The PROS-IT CNR study: comorbidities and medications at the time of diagnosis of prostate cancer. (April 2016) Authors: Magrini, S.; Ricardi, U.; Bertoni, F.; Corvò, R.; Russi, E.; Santoni, R.; Artibani, W.; Bassi, P.; Bracarda, S.; Conti, G.; Gacci, M.; Graziotti, P.; Maggi, S.; Mirone, V.; Montironi, R.; Muto, G.; Noale, M.; Pecoraro, S.; Porreca, A.; Tubaro, A. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗